Toshiba America MedicalSystems last week unveiled Capasee, a compact ob/gyn ultrasoundsystem it is introducing into the U.S. The Tustin, CA, vendorwill market the system as a portable ultrasound scanner for privateoffice applications. Capasee has been
Toshiba America MedicalSystems last week unveiled Capasee, a compact ob/gyn ultrasoundsystem it is introducing into the U.S. The Tustin, CA, vendorwill market the system as a portable ultrasound scanner for privateoffice applications.
Capasee has been marketed in Europe and Japan and has builtup an installed base of 4000 units in those market segments sinceits introduction two years ago. Toshiba demonstrated the systemfor the first time in the U.S. at this month's American Collegeof Obstetricians and Gynecologists in Orlando, FL.
Toshiba will market Capasee to obstetricians and gynecologistswho have been unable to buy ultrasound systems from major manufacturersdue to cost considerations. Capasee will be priced in the mid-$30,000range. The scanner is awaiting Food and Drug Administration 510(k)clearance.
Capasee will be distributed through Imaging Associates, a Charlotte,NC, firm that specializes in marketing medical equipment to private-practicephysicians.
Can Abbreviated MRI Have an Impact in Rectal Cancer Staging?
April 4th 2025Abbreviated MRI demonstrated a 95.3 percent specificity for rectal cancer and provided strong agreement with the full MRI protocol for T staging and detection of extramural venous invasion, according to newly published research.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
GE HealthCare Debuts AI-Powered Cardiac CT Device at ACC Conference
April 1st 2025Featuring enhanced low-dose image quality with motion-free images, the Revolution Vibe CT system reportedly facilitates improved diagnostic clarity for patients with conditions ranging from in-stent restenosis to atrial fibrillation.